Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Wall Street
Price Targets
Price Targets Summary
Mayinglong Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Mayinglong Pharmaceutical Group Co Ltd is 38.63 CNY with a low forecast of 37.62 CNY and a high forecast of 40.43 CNY.
Revenue
Forecast
Revenue Estimate
Mayinglong Pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 15%.
Operating Income
Forecast
Operating Income Estimate
Mayinglong Pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's operating income is 13%. The projected CAGR for the next 3 years is 17%.
Net Income
Forecast
Net Income Estimate
Mayinglong Pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's net income is 10%. The projected CAGR for the next 3 years is 18%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Mayinglong Pharmaceutical Group Co Ltd's stock price target?
Price Target
38.63
CNY
According to Wall Street analysts, the average 1-year price target for Mayinglong Pharmaceutical Group Co Ltd is 38.63 CNY with a low forecast of 37.62 CNY and a high forecast of 40.43 CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
15%
For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 15%.
What is Mayinglong Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
17%
For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's operating income is 13%. The projected CAGR for the next 3 years is 17%.
What is Mayinglong Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
18%
For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's net income is 10%. The projected CAGR for the next 3 years is 18%.